Rank | Gene Set | Z-score |
---|---|---|
1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 6.12583478 |
2 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.46317961 |
3 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.46317961 |
4 | modulation by symbiont of host immune response (GO:0052553) | 5.46317961 |
5 | positive regulation by symbiont of host defense response (GO:0052509) | 5.46317961 |
6 | modulation by symbiont of host defense response (GO:0052031) | 5.46317961 |
7 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.46317961 |
8 | detection of other organism (GO:0098543) | 4.74217456 |
9 | response to peptidoglycan (GO:0032494) | 4.59617593 |
10 | detection of bacterium (GO:0016045) | 4.59066216 |
11 | macrophage activation involved in immune response (GO:0002281) | 4.53224786 |
12 | neutrophil activation involved in immune response (GO:0002283) | 4.46381791 |
13 | detection of external biotic stimulus (GO:0098581) | 4.14967689 |
14 | detection of molecule of bacterial origin (GO:0032490) | 4.12407821 |
15 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.82870714 |
16 | regulation of integrin activation (GO:0033623) | 3.70564512 |
17 | detection of biotic stimulus (GO:0009595) | 3.64566219 |
18 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.63838660 |
19 | embryonic process involved in female pregnancy (GO:0060136) | 3.63351691 |
20 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.60609466 |
21 | neutrophil activation (GO:0042119) | 3.55512588 |
22 | response to host immune response (GO:0052572) | 3.54684407 |
23 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.54684407 |
24 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.52088323 |
25 | response to muramyl dipeptide (GO:0032495) | 3.47728104 |
26 | response to host defenses (GO:0052200) | 3.45246246 |
27 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.45246246 |
28 | response to host (GO:0075136) | 3.45246246 |
29 | regulation of mast cell degranulation (GO:0043304) | 3.45183559 |
30 | positive thymic T cell selection (GO:0045059) | 3.42772603 |
31 | respiratory burst (GO:0045730) | 3.40381690 |
32 | immunoglobulin mediated immune response (GO:0016064) | 3.39578449 |
33 | germinal center formation (GO:0002467) | 3.35999147 |
34 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.34415778 |
35 | apoptotic process involved in morphogenesis (GO:0060561) | 3.33217668 |
36 | response to interleukin-15 (GO:0070672) | 3.28693132 |
37 | granulocyte activation (GO:0036230) | 3.26881188 |
38 | embryonic placenta development (GO:0001892) | 3.23679113 |
39 | establishment of apical/basal cell polarity (GO:0035089) | 3.23445430 |
40 | response to laminar fluid shear stress (GO:0034616) | 3.23311741 |
41 | regulation of leukocyte degranulation (GO:0043300) | 3.22306351 |
42 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.21269178 |
43 | macrophage activation (GO:0042116) | 3.20160953 |
44 | anatomical structure regression (GO:0060033) | 3.18716696 |
45 | type I interferon signaling pathway (GO:0060337) | 3.17533605 |
46 | cellular response to type I interferon (GO:0071357) | 3.17533605 |
47 | response to type I interferon (GO:0034340) | 3.16780007 |
48 | myeloid cell activation involved in immune response (GO:0002275) | 3.16691877 |
49 | positive regulation of SMAD protein import into nucleus (GO:0060391) | 3.11627049 |
50 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.10646975 |
51 | positive regulation of histone deacetylation (GO:0031065) | 3.10497837 |
52 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.09040527 |
53 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.04182963 |
54 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.04003432 |
55 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.03017242 |
56 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.00779227 |
57 | trophectodermal cell differentiation (GO:0001829) | 2.97694989 |
58 | neutrophil mediated immunity (GO:0002446) | 2.94879496 |
59 | proline biosynthetic process (GO:0006561) | 2.94811538 |
60 | heterochromatin organization (GO:0070828) | 2.93936862 |
61 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.91478584 |
62 | B cell receptor signaling pathway (GO:0050853) | 2.90266224 |
63 | microglial cell activation (GO:0001774) | 2.90197402 |
64 | cellular response to interleukin-15 (GO:0071350) | 2.89809405 |
65 | regulation of SMAD protein import into nucleus (GO:0060390) | 2.89632053 |
66 | regulation of T cell tolerance induction (GO:0002664) | 2.89578488 |
67 | negative regulation of T cell mediated immunity (GO:0002710) | 2.89563344 |
68 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.89286535 |
69 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.88631916 |
70 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.87359871 |
71 | regulation of translational fidelity (GO:0006450) | 2.86532735 |
72 | regulation of posttranscriptional gene silencing (GO:0060147) | 2.86369982 |
73 | regulation of gene silencing by miRNA (GO:0060964) | 2.86369982 |
74 | regulation of gene silencing by RNA (GO:0060966) | 2.86369982 |
75 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.85024432 |
76 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.83835012 |
77 | regulation of gamma-delta T cell activation (GO:0046643) | 2.82664470 |
78 | regulation of tolerance induction (GO:0002643) | 2.81895298 |
79 | protein heterotrimerization (GO:0070208) | 2.80048109 |
80 | pre-miRNA processing (GO:0031054) | 2.79765309 |
81 | NIK/NF-kappaB signaling (GO:0038061) | 2.79349688 |
82 | positive regulation of mast cell activation (GO:0033005) | 2.79007924 |
83 | negative regulation of type 2 immune response (GO:0002829) | 2.76084271 |
84 | regulation of regulated secretory pathway (GO:1903305) | 2.75156283 |
85 | maternal placenta development (GO:0001893) | 2.75031339 |
86 | negative regulation of interleukin-6 production (GO:0032715) | 2.74030768 |
87 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.73849316 |
88 | defense response to protozoan (GO:0042832) | 2.73314478 |
89 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.72408416 |
90 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.71758178 |
91 | endothelial cell chemotaxis (GO:0035767) | 2.70909799 |
92 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.69836322 |
93 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.69680156 |
94 | thymic T cell selection (GO:0045061) | 2.68871180 |
95 | leukocyte aggregation (GO:0070486) | 2.68694069 |
96 | regulation of mast cell activation (GO:0033003) | 2.68312221 |
97 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.67732531 |
98 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.67507397 |
99 | negative regulation of interleukin-12 production (GO:0032695) | 2.65437884 |
100 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.64536410 |
101 | leukocyte degranulation (GO:0043299) | 2.61555772 |
102 | endothelial tube morphogenesis (GO:0061154) | 2.61409831 |
103 | morphogenesis of an endothelium (GO:0003159) | 2.61409831 |
104 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.59201692 |
105 | endodermal cell differentiation (GO:0035987) | 2.58663067 |
106 | negative regulation of innate immune response (GO:0045824) | 2.58416191 |
107 | regulation of macrophage cytokine production (GO:0010935) | 2.56170951 |
108 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.55688596 |
109 | regulation of B cell differentiation (GO:0045577) | 2.53052592 |
110 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.52018521 |
111 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.52018521 |
112 | * regulation of T-helper 2 cell differentiation (GO:0045628) | 2.49405454 |
113 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.48133145 |
114 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.48133145 |
115 | establishment of monopolar cell polarity (GO:0061162) | 2.47445360 |
116 | establishment or maintenance of monopolar cell polarity (GO:0061339) | 2.47445360 |
117 | paraxial mesoderm development (GO:0048339) | 2.45924458 |
118 | cellular extravasation (GO:0045123) | 2.45885284 |
119 | dosage compensation (GO:0007549) | 2.45555923 |
120 | apoptotic process involved in development (GO:1902742) | 2.45045852 |
121 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.43600600 |
122 | nodal signaling pathway (GO:0038092) | 2.42893468 |
123 | positive T cell selection (GO:0043368) | 2.40857851 |
124 | negative regulation of stress fiber assembly (GO:0051497) | 2.40844392 |
125 | basement membrane organization (GO:0071711) | 2.40186986 |
126 | mRNA stabilization (GO:0048255) | 2.39644583 |
127 | RNA stabilization (GO:0043489) | 2.39644583 |
128 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 2.39003469 |
129 | regulation of hippo signaling (GO:0035330) | 2.36127406 |
130 | regulation of establishment of planar polarity involved in neural tube closure (GO:0090178) | 2.34319785 |
131 | response to UV-C (GO:0010225) | 2.32757930 |
132 | positive regulation of lamellipodium assembly (GO:0010592) | 2.31796083 |
133 | positive regulation of protein deacetylation (GO:0090312) | 2.31534643 |
134 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.30944155 |
135 | negative regulation of cell killing (GO:0031342) | 2.30944155 |
136 | polarized epithelial cell differentiation (GO:0030859) | 2.28374274 |
137 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.27192904 |
138 | positive regulation of protein homooligomerization (GO:0032464) | 2.25988022 |
139 | negative regulation of fatty acid transport (GO:2000192) | 2.24907852 |
140 | negative thymic T cell selection (GO:0045060) | 2.22158804 |
141 | nuclear pore complex assembly (GO:0051292) | 2.21967720 |
142 | blood vessel endothelial cell migration (GO:0043534) | 2.21772949 |
143 | tolerance induction (GO:0002507) | 2.21644432 |
144 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.20989328 |
145 | positive regulation of epithelial to mesenchymal transition (GO:0010718) | 2.19739446 |
146 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.19268548 |
147 | T cell apoptotic process (GO:0070231) | 2.18702014 |
148 | negative T cell selection (GO:0043383) | 2.16807658 |
149 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.16794139 |
150 | regulation of cholesterol homeostasis (GO:2000188) | 2.15466721 |
151 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.15189232 |
152 | leukocyte cell-cell adhesion (GO:0007159) | 2.14961744 |
153 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.13976775 |
154 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 2.12103914 |
155 | response to fluid shear stress (GO:0034405) | 2.11688820 |
156 | T cell selection (GO:0045058) | 2.10529938 |
157 | establishment of endothelial barrier (GO:0061028) | 2.10208961 |
158 | nuclear pore organization (GO:0006999) | 2.09812744 |
159 | germ cell migration (GO:0008354) | 2.09264387 |
160 | negative regulation of glial cell proliferation (GO:0060253) | 2.08732967 |
161 | regulation of tight junction assembly (GO:2000810) | 2.08052977 |
162 | * intracellular estrogen receptor signaling pathway (GO:0030520) | 2.07551166 |
163 | positive regulation of T cell apoptotic process (GO:0070234) | 2.07326287 |
164 | cell-substrate junction assembly (GO:0007044) | 2.07154435 |
165 | * apoptotic cell clearance (GO:0043277) | 2.06359186 |
166 | regulation of RNA export from nucleus (GO:0046831) | 2.05821198 |
167 | regulation of protein heterodimerization activity (GO:0043497) | 2.05485795 |
168 | adherens junction assembly (GO:0034333) | 2.05074936 |
169 | negative regulation of cardiac muscle tissue growth (GO:0055022) | 2.04740918 |
170 | negative regulation of heart growth (GO:0061117) | 2.04740918 |
171 | mitotic nuclear envelope disassembly (GO:0007077) | 2.03921605 |
172 | skin morphogenesis (GO:0043589) | 2.03783944 |
173 | cell migration involved in sprouting angiogenesis (GO:0002042) | 2.03178309 |
174 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.03003257 |
175 | developmental programmed cell death (GO:0010623) | 2.02474184 |
176 | negative regulation of phagocytosis (GO:0050765) | 2.02016804 |
177 | regulation of stem cell maintenance (GO:2000036) | 2.01698750 |
178 | positive regulation by host of viral transcription (GO:0043923) | 2.01482388 |
179 | NLS-bearing protein import into nucleus (GO:0006607) | 2.01474719 |
Rank | Gene Set | Z-score |
---|---|---|
1 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.41575702 |
2 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.32626921 |
3 | MYC_22102868_ChIP-Seq_BL_Human | 3.31389708 |
4 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.13817256 |
5 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.87808825 |
6 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.65413651 |
7 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.50275374 |
8 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.44240702 |
9 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.33874694 |
10 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.30772193 |
11 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 2.20843359 |
12 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 2.15406483 |
13 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 2.15406483 |
14 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 2.15406483 |
15 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.14247423 |
16 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.06395624 |
17 | * KDM2B_26808549_Chip-Seq_DND41_Human | 2.02542161 |
18 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.00675464 |
19 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.99220179 |
20 | * MAF_26560356_Chip-Seq_TH1_Human | 1.94265353 |
21 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.83694179 |
22 | * TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.81864614 |
23 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.78711604 |
24 | UTX_26944678_Chip-Seq_JUKART_Human | 1.76420078 |
25 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.75181480 |
26 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.69518048 |
27 | * ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.68942842 |
28 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.66713919 |
29 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.61534507 |
30 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.61419679 |
31 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.59684767 |
32 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.59222981 |
33 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.58656050 |
34 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.57890176 |
35 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.56235717 |
36 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.53730398 |
37 | * SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.52453482 |
38 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.52413533 |
39 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.51371195 |
40 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.50023801 |
41 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.49365611 |
42 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.49077932 |
43 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.48462792 |
44 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.47264893 |
45 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.45970447 |
46 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.45352392 |
47 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.42704632 |
48 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.42013196 |
49 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.40561087 |
50 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.40069435 |
51 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.38898904 |
52 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.37962103 |
53 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.37285264 |
54 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.36254692 |
55 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.36197141 |
56 | * ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.36195362 |
57 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.35559983 |
58 | MYB_26560356_Chip-Seq_TH1_Human | 1.35107642 |
59 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.34936427 |
60 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.34025357 |
61 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.33932493 |
62 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.33487242 |
63 | P68_20966046_ChIP-Seq_HELA_Human | 1.33112253 |
64 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.32840947 |
65 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.32452592 |
66 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.32358311 |
67 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.32212231 |
68 | MYB_26560356_Chip-Seq_TH2_Human | 1.32003900 |
69 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.31059677 |
70 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.30395914 |
71 | MAF_26560356_Chip-Seq_TH2_Human | 1.30316579 |
72 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.27371266 |
73 | * ATF3_27146783_Chip-Seq_COLON_Human | 1.27198494 |
74 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.27050054 |
75 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.26216791 |
76 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.24646615 |
77 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.24498275 |
78 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.23425139 |
79 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.22897140 |
80 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.22771100 |
81 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.21923382 |
82 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.21748882 |
83 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.21703983 |
84 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.21679915 |
85 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.21517430 |
86 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.21462390 |
87 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.21033310 |
88 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.20896434 |
89 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.20510849 |
90 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.18778837 |
91 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.18571518 |
92 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.18348545 |
93 | * EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.18119665 |
94 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.17795225 |
95 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.16318152 |
96 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.16144696 |
97 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.15510632 |
98 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.15498360 |
99 | * RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.15052005 |
100 | GATA1_19941826_ChIP-Seq_K562_Human | 1.14849599 |
101 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.14548501 |
102 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.14531986 |
103 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.12341476 |
104 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.12313825 |
105 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.11202530 |
106 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.11184668 |
107 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.10381644 |
108 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.09548969 |
109 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.07414313 |
110 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.06798159 |
111 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.06658180 |
112 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.05125762 |
113 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.05020729 |
114 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.04813430 |
115 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.03947179 |
116 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.03603789 |
117 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.03106982 |
118 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.01671076 |
119 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.01571399 |
120 | * RUNX_20019798_ChIP-Seq_JUKART_Human | 1.01514335 |
121 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 0.99875352 |
122 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.99171057 |
123 | * PU_27001747_Chip-Seq_BMDM_Mouse | 0.98389931 |
124 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.97871859 |
125 | * DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.97809731 |
126 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.97330041 |
127 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.96884503 |
128 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.96330806 |
129 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.96309346 |
130 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.96053982 |
131 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.95904229 |
132 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 0.95882705 |
133 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.94644433 |
134 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 0.94215790 |
135 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 0.93221814 |
136 | * KDM2B_26808549_Chip-Seq_K562_Human | 0.92289371 |
137 | * CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.91968628 |
138 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.91747245 |
139 | SPI1_23127762_ChIP-Seq_K562_Human | 0.91483165 |
140 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.91420636 |
141 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.90474954 |
142 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.89895282 |
143 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.89800908 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003724_increased_susceptibility_to | 4.10704374 |
2 | MP0003705_abnormal_hypodermis_morpholog | 3.32977461 |
3 | MP0005076_abnormal_cell_differentiation | 2.86501752 |
4 | MP0009278_abnormal_bone_marrow | 2.74340068 |
5 | MP0010352_gastrointestinal_tract_polyps | 2.63804804 |
6 | MP0003191_abnormal_cellular_cholesterol | 2.57229824 |
7 | MP0009785_altered_susceptibility_to | 2.31105781 |
8 | MP0005451_abnormal_body_composition | 2.29376225 |
9 | MP0003303_peritoneal_inflammation | 2.23558000 |
10 | MP0008260_abnormal_autophagy | 2.23365753 |
11 | MP0005671_abnormal_response_to | 2.17984303 |
12 | MP0008438_abnormal_cutaneous_collagen | 2.15410568 |
13 | MP0003436_decreased_susceptibility_to | 2.14316756 |
14 | MP0003172_abnormal_lysosome_physiology | 2.10489546 |
15 | MP0003566_abnormal_cell_adhesion | 2.10326695 |
16 | MP0003300_gastrointestinal_ulcer | 1.99947154 |
17 | MP0010030_abnormal_orbit_morphology | 1.99588168 |
18 | MP0000685_abnormal_immune_system | 1.96005435 |
19 | MP0005058_abnormal_lysosome_morphology | 1.86921911 |
20 | MP0005023_abnormal_wound_healing | 1.82971253 |
21 | MP0002148_abnormal_hypersensitivity_rea | 1.79120013 |
22 | MP0005464_abnormal_platelet_physiology | 1.69757590 |
23 | MP0003279_aneurysm | 1.69511304 |
24 | MP0004381_abnormal_hair_follicle | 1.67113362 |
25 | MP0002405_respiratory_system_inflammati | 1.55421717 |
26 | MP0003453_abnormal_keratinocyte_physiol | 1.55039469 |
27 | MP0003183_abnormal_peptide_metabolism | 1.54525786 |
28 | MP0002396_abnormal_hematopoietic_system | 1.51808030 |
29 | MP0003866_abnormal_defecation | 1.51791901 |
30 | MP0005387_immune_system_phenotype | 1.50129462 |
31 | MP0001790_abnormal_immune_system | 1.50129462 |
32 | MP0002998_abnormal_bone_remodeling | 1.49166390 |
33 | MP0001545_abnormal_hematopoietic_system | 1.45798174 |
34 | MP0005397_hematopoietic_system_phenotyp | 1.45798174 |
35 | MP0003763_abnormal_thymus_physiology | 1.41386335 |
36 | MP0001800_abnormal_humoral_immune | 1.40291803 |
37 | MP0000465_gastrointestinal_hemorrhage | 1.38123204 |
38 | MP0000733_abnormal_muscle_development | 1.34448542 |
39 | MP0004510_myositis | 1.33750036 |
40 | MP0008469_abnormal_protein_level | 1.31344929 |
41 | MP0005275_abnormal_skin_tensile | 1.29933421 |
42 | MP0003828_pulmonary_edema | 1.28792893 |
43 | MP0003448_altered_tumor_morphology | 1.28346517 |
44 | MP0001851_eye_inflammation | 1.27903588 |
45 | MP0004883_abnormal_blood_vessel | 1.26189620 |
46 | MP0004808_abnormal_hematopoietic_stem | 1.25160274 |
47 | MP0010155_abnormal_intestine_physiology | 1.24745518 |
48 | MP0003075_altered_response_to | 1.23802299 |
49 | MP0004197_abnormal_fetal_growth/weight/ | 1.22498238 |
50 | MP0000490_abnormal_crypts_of | 1.21619127 |
51 | MP0000858_altered_metastatic_potential | 1.21429450 |
52 | MP0005310_abnormal_salivary_gland | 1.20399031 |
53 | MP0008057_abnormal_DNA_replication | 1.19422831 |
54 | MP0002452_abnormal_antigen_presenting | 1.19282448 |
55 | MP0009764_decreased_sensitivity_to | 1.19063516 |
56 | MP0010307_abnormal_tumor_latency | 1.18856914 |
57 | MP0001873_stomach_inflammation | 1.17847012 |
58 | MP0009333_abnormal_splenocyte_physiolog | 1.17204495 |
59 | MP0002086_abnormal_extraembryonic_tissu | 1.16513232 |
60 | MP0004947_skin_inflammation | 1.16217591 |
61 | MP0002933_joint_inflammation | 1.15441313 |
62 | MP0002060_abnormal_skin_morphology | 1.14089585 |
63 | MP0002166_altered_tumor_susceptibility | 1.13542717 |
64 | MP0002398_abnormal_bone_marrow | 1.13093494 |
65 | MP0001835_abnormal_antigen_presentation | 1.11957674 |
66 | MP0000767_abnormal_smooth_muscle | 1.10646982 |
67 | MP0003091_abnormal_cell_migration | 1.08362745 |
68 | MP0005164_abnormal_response_to | 1.05723913 |
69 | MP0001849_ear_inflammation | 1.05075288 |
70 | MP0005166_decreased_susceptibility_to | 1.04929131 |
71 | MP0002420_abnormal_adaptive_immunity | 1.04707965 |
72 | MP0001819_abnormal_immune_cell | 1.03754449 |
73 | MP0004264_abnormal_extraembryonic_tissu | 1.02462537 |
74 | MP0002722_abnormal_immune_system | 1.02194000 |
75 | MP0005000_abnormal_immune_tolerance | 1.01955398 |
76 | MP0005503_abnormal_tendon_morphology | 1.01467484 |
77 | MP0000689_abnormal_spleen_morphology | 1.00866199 |
78 | MP0002088_abnormal_embryonic_growth/wei | 1.00312018 |
79 | * MP0000703_abnormal_thymus_morphology | 0.99752659 |
80 | MP0003984_embryonic_growth_retardation | 0.99652272 |
81 | MP0002723_abnormal_immune_serum | 0.99554426 |
82 | MP0004858_abnormal_nervous_system | 0.99325630 |
83 | MP0005380_embryogenesis_phenotype | 0.97850202 |
84 | MP0001672_abnormal_embryogenesis/_devel | 0.97850202 |
85 | MP0000350_abnormal_cell_proliferation | 0.97848387 |
86 | * MP0002925_abnormal_cardiovascular_devel | 0.97798655 |
87 | MP0005083_abnormal_biliary_tract | 0.97225548 |
88 | MP0003045_fibrosis | 0.97027648 |
89 | MP0001533_abnormal_skeleton_physiology | 0.96955458 |
90 | MP0000716_abnormal_immune_system | 0.96671008 |
91 | MP0005025_abnormal_response_to | 0.95960401 |
92 | MP0001853_heart_inflammation | 0.95891281 |
93 | MP0004185_abnormal_adipocyte_glucose | 0.94931728 |
94 | * MP0005390_skeleton_phenotype | 0.91818850 |
95 | MP0002419_abnormal_innate_immunity | 0.91551266 |
96 | MP0001958_emphysema | 0.90403551 |
97 | MP0001915_intracranial_hemorrhage | 0.89071978 |
98 | * MP0002085_abnormal_embryonic_tissue | 0.88681826 |
99 | MP0001697_abnormal_embryo_size | 0.88679424 |
100 | MP0005377_hearing/vestibular/ear_phenot | 0.88605648 |
101 | MP0003878_abnormal_ear_physiology | 0.88605648 |
102 | MP0002277_abnormal_respiratory_mucosa | 0.88372407 |
103 | MP0001730_embryonic_growth_arrest | 0.88357735 |
104 | MP0001243_abnormal_dermal_layer | 0.88321204 |
105 | * MP0005508_abnormal_skeleton_morphology | 0.88242377 |
106 | MP0002429_abnormal_blood_cell | 0.87832864 |
107 | MP0002084_abnormal_developmental_patter | 0.87159098 |
108 | MP0010630_abnormal_cardiac_muscle | 0.85566965 |
109 | MP0000249_abnormal_blood_vessel | 0.85535010 |
110 | MP0009840_abnormal_foam_cell | 0.85501617 |
111 | MP0002019_abnormal_tumor_incidence | 0.85233492 |
112 | MP0003077_abnormal_cell_cycle | 0.84951798 |
113 | MP0003567_abnormal_fetal_cardiomyocyte | 0.84047592 |
114 | MP0001845_abnormal_inflammatory_respons | 0.83756398 |
115 | MP0002006_tumorigenesis | 0.83386461 |
116 | MP0004957_abnormal_blastocyst_morpholog | 0.83033726 |
117 | MP0004272_abnormal_basement_membrane | 0.82990211 |
118 | MP0001348_abnormal_lacrimal_gland | 0.82884623 |
119 | MP0008961_abnormal_basal_metabolism | 0.81436669 |
120 | MP0003690_abnormal_glial_cell | 0.80983054 |
121 | MP0003941_abnormal_skin_development | 0.80162947 |
122 | MP0003795_abnormal_bone_structure | 0.79966548 |
123 | MP0002877_abnormal_melanocyte_morpholog | 0.79775902 |
124 | MP0000477_abnormal_intestine_morphology | 0.79367745 |
125 | MP0000343_altered_response_to | 0.79356335 |
126 | MP0001293_anophthalmia | 0.77696301 |
127 | MP0008004_abnormal_stomach_pH | 0.77426456 |
128 | MP0006082_CNS_inflammation | 0.76650698 |
129 | MP0005623_abnormal_meninges_morphology | 0.76649333 |
130 | MP0002138_abnormal_hepatobiliary_system | 0.76591248 |
131 | * MP0002282_abnormal_trachea_morphology | 0.75604869 |
132 | MP0008874_decreased_physiological_sensi | 0.75044358 |
133 | MP0005409_darkened_coat_color | 0.74797405 |
134 | MP0002089_abnormal_postnatal_growth/wei | 0.74695804 |
135 | MP0002653_abnormal_ependyma_morphology | 0.74580201 |
136 | MP0003385_abnormal_body_wall | 0.74178106 |
137 | MP0001663_abnormal_digestive_system | 0.73718608 |
138 | MP0000604_amyloidosis | 0.73278286 |
139 | MP0005410_abnormal_fertilization | 0.66914344 |
140 | * MP0002132_abnormal_respiratory_system | 0.65593947 |
141 | MP0009763_increased_sensitivity_to | 0.63103836 |
142 | MP0005666_abnormal_adipose_tissue | 0.61930672 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Abnormality of macrophages (HP:0004311) | 4.74576099 |
2 | Recurrent bacterial skin infections (HP:0005406) | 4.66875545 |
3 | Orchitis (HP:0100796) | 4.54859246 |
4 | Retrobulbar optic neuritis (HP:0100654) | 3.99461170 |
5 | Optic neuritis (HP:0100653) | 3.99461170 |
6 | Protrusio acetabuli (HP:0003179) | 3.95458175 |
7 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.89077179 |
8 | Cerebral aneurysm (HP:0004944) | 3.68230881 |
9 | Gastrointestinal infarctions (HP:0005244) | 3.59297246 |
10 | Stomatitis (HP:0010280) | 3.54070521 |
11 | Chronic obstructive pulmonary disease (HP:0006510) | 3.49001897 |
12 | Obstructive lung disease (HP:0006536) | 3.49001897 |
13 | Increased IgE level (HP:0003212) | 3.40896035 |
14 | Meningitis (HP:0001287) | 3.27393623 |
15 | Recurrent skin infections (HP:0001581) | 3.02985088 |
16 | Shallow orbits (HP:0000586) | 2.99958076 |
17 | Short 4th metacarpal (HP:0010044) | 2.94308659 |
18 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 2.94308659 |
19 | Keratoconjunctivitis sicca (HP:0001097) | 2.88738815 |
20 | Prolonged bleeding time (HP:0003010) | 2.88430926 |
21 | Ankle contracture (HP:0006466) | 2.85807979 |
22 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.83318758 |
23 | Vasculitis (HP:0002633) | 2.83158907 |
24 | Pustule (HP:0200039) | 2.80631578 |
25 | Urticaria (HP:0001025) | 2.79847170 |
26 | Chest pain (HP:0100749) | 2.76274183 |
27 | Hypochromic anemia (HP:0001931) | 2.75435758 |
28 | Eczematoid dermatitis (HP:0000976) | 2.73907170 |
29 | Peritonitis (HP:0002586) | 2.73841459 |
30 | Amyloidosis (HP:0011034) | 2.71993853 |
31 | Alopecia of scalp (HP:0002293) | 2.70996025 |
32 | Hypochromic microcytic anemia (HP:0004840) | 2.68770381 |
33 | Ulnar bowing (HP:0003031) | 2.65613133 |
34 | Encephalitis (HP:0002383) | 2.63706516 |
35 | Premature rupture of membranes (HP:0001788) | 2.63450333 |
36 | Keratoconjunctivitis (HP:0001096) | 2.54965885 |
37 | Increased density of long bones (HP:0006392) | 2.54058693 |
38 | Recurrent cutaneous fungal infections (HP:0011370) | 2.53151740 |
39 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.53151740 |
40 | Mitral valve prolapse (HP:0001634) | 2.51788224 |
41 | Aortic aneurysm (HP:0004942) | 2.51031388 |
42 | Episodic fever (HP:0001954) | 2.45533309 |
43 | Hemoptysis (HP:0002105) | 2.42132945 |
44 | Epistaxis (HP:0000421) | 2.40141511 |
45 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.39098369 |
46 | Gingival bleeding (HP:0000225) | 2.38246587 |
47 | Genu recurvatum (HP:0002816) | 2.37171810 |
48 | Arterial thrombosis (HP:0004420) | 2.37143426 |
49 | Pulmonary infiltrates (HP:0002113) | 2.35642247 |
50 | Aortic dissection (HP:0002647) | 2.35627128 |
51 | Selective tooth agenesis (HP:0001592) | 2.35457560 |
52 | Increased cerebral lipofuscin (HP:0011813) | 2.32193238 |
53 | Myocardial infarction (HP:0001658) | 2.31212663 |
54 | Increased connective tissue (HP:0009025) | 2.31099338 |
55 | Abnormality of the 4th metacarpal (HP:0010012) | 2.25948118 |
56 | Loss of speech (HP:0002371) | 2.21080972 |
57 | Asymmetric septal hypertrophy (HP:0001670) | 2.20149229 |
58 | Interstitial pulmonary disease (HP:0006530) | 2.19924195 |
59 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.19041968 |
60 | Dilatation of the ascending aorta (HP:0005111) | 2.18514696 |
61 | Purpura (HP:0000979) | 2.16244983 |
62 | Petechiae (HP:0000967) | 2.14462978 |
63 | Pulmonary embolism (HP:0002204) | 2.14041564 |
64 | Osteomyelitis (HP:0002754) | 2.10733534 |
65 | Spontaneous hematomas (HP:0007420) | 2.09695042 |
66 | Dysostosis multiplex (HP:0000943) | 2.09579465 |
67 | Slow saccadic eye movements (HP:0000514) | 2.07890921 |
68 | Aneurysm (HP:0002617) | 2.07462230 |
69 | Recurrent viral infections (HP:0004429) | 2.05725775 |
70 | Recurrent fungal infections (HP:0002841) | 2.03232303 |
71 | Distal lower limb muscle weakness (HP:0009053) | 2.03168652 |
72 | Abnormality of the peritoneum (HP:0002585) | 2.01709501 |
73 | Anorexia (HP:0002039) | 2.01618518 |
74 | Spinal cord lesions (HP:0100561) | 2.00913981 |
75 | Syringomyelia (HP:0003396) | 2.00913981 |
76 | Hemorrhage of the eye (HP:0011885) | 1.98344720 |
77 | Leukocytosis (HP:0001974) | 1.98178474 |
78 | Atrophic scars (HP:0001075) | 1.97977599 |
79 | Metaphyseal cupping (HP:0003021) | 1.97342174 |
80 | Basal cell carcinoma (HP:0002671) | 1.97331700 |
81 | Rib fusion (HP:0000902) | 1.96871887 |
82 | Sepsis (HP:0100806) | 1.96858211 |
83 | Broad face (HP:0000283) | 1.96809693 |
84 | Blue sclerae (HP:0000592) | 1.96723957 |
85 | Abnormality of the fingertips (HP:0001211) | 1.96630149 |
86 | Increased serum ferritin (HP:0003281) | 1.96536541 |
87 | Obstructive sleep apnea (HP:0002870) | 1.96378511 |
88 | Rectal prolapse (HP:0002035) | 1.95076971 |
89 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.93725877 |
90 | Broad metatarsal (HP:0001783) | 1.93691588 |
91 | Disproportionate tall stature (HP:0001519) | 1.90786917 |
92 | Slender build (HP:0001533) | 1.89402596 |
93 | Hypergammaglobulinemia (HP:0010702) | 1.87438515 |
94 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.87191201 |
95 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.87191201 |
96 | Abnormality of glycolipid metabolism (HP:0010969) | 1.87191201 |
97 | Microcytic anemia (HP:0001935) | 1.86235969 |
98 | Abnormality of the endocardium (HP:0004306) | 1.85741035 |
99 | Abnormality of the nasal mucosa (HP:0000433) | 1.85129226 |
100 | Granulocytopenia (HP:0001913) | 1.84956601 |
101 | Cervical subluxation (HP:0003308) | 1.84940461 |
102 | Glomerulopathy (HP:0100820) | 1.84260490 |
103 | Renal duplication (HP:0000075) | 1.83862248 |
104 | Abnormality of the pleura (HP:0002103) | 1.83858396 |
105 | Hypertriglyceridemia (HP:0002155) | 1.83854921 |
106 | Type 1 muscle fiber predominance (HP:0003803) | 1.83592607 |
107 | Acne (HP:0001061) | 1.83046165 |
108 | Wrist flexion contracture (HP:0001239) | 1.82933797 |
109 | Premature loss of primary teeth (HP:0006323) | 1.82743165 |
110 | Easy fatigability (HP:0003388) | 1.81674585 |
111 | Increased IgM level (HP:0003496) | 1.81496491 |
112 | Cellulitis (HP:0100658) | 1.81426844 |
113 | Bladder diverticulum (HP:0000015) | 1.81377100 |
114 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.80200575 |
115 | Osteolytic defects of the hand bones (HP:0009699) | 1.79797828 |
116 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.79797828 |
117 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.79049175 |
118 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.79049175 |
119 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.79049175 |
120 | Skin ulcer (HP:0200042) | 1.78252262 |
121 | Gastrointestinal stroma tumor (HP:0100723) | 1.77901717 |
122 | Hyperacusis (HP:0010780) | 1.77466217 |
123 | Supernumerary ribs (HP:0005815) | 1.77347048 |
124 | Emphysema (HP:0002097) | 1.76957508 |
125 | Restrictive lung disease (HP:0002091) | 1.76473451 |
126 | Hematochezia (HP:0002573) | 1.73637509 |
127 | Nasal polyposis (HP:0100582) | 1.73222035 |
128 | Milia (HP:0001056) | 1.72983976 |
129 | Fragile skin (HP:0001030) | 1.71159982 |
130 | Bowing of the arm (HP:0006488) | 1.70547405 |
131 | Bowed forearm bones (HP:0003956) | 1.70547405 |
132 | Recurrent abscess formation (HP:0002722) | 1.70188762 |
133 | Esophageal varix (HP:0002040) | 1.69718525 |
134 | Cheilitis (HP:0100825) | 1.69692057 |
135 | Long eyelashes (HP:0000527) | 1.69386515 |
136 | Periodontitis (HP:0000704) | 1.69204492 |
137 | Abnormal platelet volume (HP:0011876) | 1.68986260 |
138 | Myositis (HP:0100614) | 1.68408645 |
139 | Colitis (HP:0002583) | 1.67345147 |
140 | Bicuspid aortic valve (HP:0001647) | 1.66942854 |
141 | Broad toe (HP:0001837) | 1.66907744 |
142 | Hand muscle atrophy (HP:0009130) | 1.65562711 |
143 | Broad thumb (HP:0011304) | 1.65123087 |
144 | Bilateral sensorineural hearing impairment (HP:0008619) | 1.64729699 |
145 | Vertebral fusion (HP:0002948) | 1.64542334 |
146 | Gastrointestinal inflammation (HP:0004386) | 1.64378764 |
147 | Polycythemia (HP:0001901) | 1.63497514 |
148 | Broad palm (HP:0001169) | 1.63138543 |
149 | Camptodactyly of toe (HP:0001836) | 1.62687603 |
150 | Broad hallux (HP:0010055) | 1.61320332 |
151 | Lymphangioma (HP:0100764) | 1.61258903 |
152 | Gingivitis (HP:0000230) | 1.59495590 |
153 | Persistence of primary teeth (HP:0006335) | 1.59115613 |
154 | Spinal rigidity (HP:0003306) | 1.58387285 |
155 | Vertebral compression fractures (HP:0002953) | 1.58085854 |
156 | Thin bony cortex (HP:0002753) | 1.57778651 |
157 | Inflammation of the large intestine (HP:0002037) | 1.57738252 |
158 | Mediastinal lymphadenopathy (HP:0100721) | 1.56061650 |
159 | Short 5th finger (HP:0009237) | 1.55981839 |
160 | Increased mean platelet volume (HP:0011877) | 1.55916485 |
161 | Intestinal fistula (HP:0100819) | 1.55538009 |
162 | Short humerus (HP:0005792) | 1.55220850 |
163 | Turricephaly (HP:0000262) | 1.55052264 |
164 | IgM deficiency (HP:0002850) | 1.54905778 |
165 | Annular pancreas (HP:0001734) | 1.54670137 |
166 | Biconcave vertebral bodies (HP:0004586) | 1.54435254 |
167 | Follicular hyperkeratosis (HP:0007502) | 1.54194442 |
168 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.54188468 |
169 | Spondylolisthesis (HP:0003302) | 1.54162832 |
170 | Urethral obstruction (HP:0000796) | 1.54001274 |
171 | Dislocated radial head (HP:0003083) | 1.53402087 |
172 | Skin tags (HP:0010609) | 1.53034197 |
173 | Distal upper limb amyotrophy (HP:0007149) | 1.53014088 |
174 | Upper limb amyotrophy (HP:0009129) | 1.53014088 |
175 | Inguinal hernia (HP:0000023) | 1.52502545 |
176 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 1.51743575 |
Rank | Gene Set | Z-score |
---|---|---|
1 | RIPK4 | 3.66874651 |
2 | TRIB3 | 3.40898450 |
3 | CDK12 | 3.31730967 |
4 | MAP3K10 | 3.25519922 |
5 | MAP4K1 | 3.19878999 |
6 | PRPF4B | 2.84717494 |
7 | ERN1 | 2.80581892 |
8 | PKN2 | 2.56670828 |
9 | IRAK4 | 2.42570678 |
10 | EEF2K | 2.37021239 |
11 | STK10 | 2.30162104 |
12 | ICK | 2.12593299 |
13 | SIK1 | 2.06663688 |
14 | TNK2 | 2.06339780 |
15 | SMG1 | 1.74757214 |
16 | BMX | 1.72602698 |
17 | CSK | 1.72460150 |
18 | FES | 1.72106365 |
19 | RIPK1 | 1.67542503 |
20 | MAP3K11 | 1.65741574 |
21 | DDR2 | 1.62710480 |
22 | PDGFRA | 1.56942306 |
23 | TTN | 1.51455791 |
24 | FGFR4 | 1.46753482 |
25 | GRK6 | 1.46139941 |
26 | PIM1 | 1.44983299 |
27 | MAP3K13 | 1.44365600 |
28 | TGFBR2 | 1.44197256 |
29 | EPHB1 | 1.43680582 |
30 | PTK6 | 1.43424569 |
31 | FLT3 | 1.40822304 |
32 | KSR2 | 1.39090240 |
33 | MAP3K1 | 1.35463848 |
34 | LRRK2 | 1.34350442 |
35 | JAK3 | 1.33918786 |
36 | MARK2 | 1.32062519 |
37 | PAK4 | 1.30710944 |
38 | ZAP70 | 1.28700323 |
39 | CDK6 | 1.26128639 |
40 | RPS6KA4 | 1.24337850 |
41 | LATS1 | 1.16045350 |
42 | PIM2 | 1.14344476 |
43 | TESK1 | 1.14287109 |
44 | IKBKE | 1.14025993 |
45 | PDPK1 | 1.12920890 |
46 | EPHA2 | 1.11128673 |
47 | DMPK | 1.10786057 |
48 | MTOR | 1.09574370 |
49 | PRKD2 | 1.07956119 |
50 | CHUK | 1.06298460 |
51 | DYRK1B | 1.05583734 |
52 | TYK2 | 1.05563837 |
53 | MAP2K3 | 1.05247586 |
54 | PTK2 | 1.04278643 |
55 | SYK | 0.99375155 |
56 | NEK2 | 0.98759210 |
57 | IRAK3 | 0.98385048 |
58 | PDK1 | 0.98005227 |
59 | CDK4 | 0.94193152 |
60 | EPHA3 | 0.92660501 |
61 | CDC42BPA | 0.92037656 |
62 | STK38 | 0.91681688 |
63 | BTK | 0.91188878 |
64 | BLK | 0.91164014 |
65 | TXK | 0.89593356 |
66 | KDR | 0.89205086 |
67 | EPHB2 | 0.88487489 |
68 | LYN | 0.86729316 |
69 | BRD4 | 0.86085980 |
70 | FGR | 0.85876608 |
71 | ITK | 0.85638351 |
72 | TBK1 | 0.83175833 |
73 | LATS2 | 0.82639507 |
74 | FGFR1 | 0.82063478 |
75 | TYRO3 | 0.81341452 |
76 | * CDK7 | 0.80258542 |
77 | FGFR3 | 0.80163634 |
78 | HCK | 0.79931790 |
79 | MAPK15 | 0.79469533 |
80 | MARK3 | 0.77501619 |
81 | ALK | 0.76600443 |
82 | MAP3K3 | 0.75672733 |
83 | TESK2 | 0.73070795 |
84 | IKBKB | 0.72905639 |
85 | IRAK2 | 0.72804232 |
86 | CAMK1D | 0.72488830 |
87 | MATK | 0.72428513 |
88 | RPS6KA2 | 0.71985775 |
89 | CSF1R | 0.71926508 |
90 | STK3 | 0.71143517 |
91 | RPS6KB2 | 0.71058389 |
92 | KIT | 0.70767675 |
93 | YES1 | 0.70684870 |
94 | RPS6KC1 | 0.70347581 |
95 | RPS6KL1 | 0.70347581 |
96 | MAP3K7 | 0.69964912 |
97 | TAOK1 | 0.69522979 |
98 | MAP3K8 | 0.69517997 |
99 | MAPK12 | 0.69265582 |
100 | MAPK7 | 0.68848998 |
101 | PDGFRB | 0.68443296 |
102 | PAK2 | 0.68180317 |
103 | RPS6KA6 | 0.67220311 |
104 | JAK1 | 0.67050021 |
105 | TRPM7 | 0.66972061 |
106 | SIK3 | 0.64963408 |
107 | RET | 0.62919504 |
108 | IRAK1 | 0.61662634 |
109 | SIK2 | 0.60419817 |
110 | PRKG2 | 0.59751577 |
111 | MAP2K2 | 0.59400422 |
112 | CDK9 | 0.59012873 |
113 | MAP3K6 | 0.58830796 |
114 | CLK1 | 0.57610607 |
115 | RPS6KA1 | 0.57090131 |
116 | TGFBR1 | 0.56164399 |
117 | MAP3K2 | 0.55667683 |
118 | LCK | 0.53966950 |
119 | GSK3A | 0.51279762 |
120 | FYN | 0.50513058 |
121 | MAPK11 | 0.50167500 |
122 | JAK2 | 0.49506207 |
123 | MAPKAPK2 | 0.47095453 |
124 | CAMKK1 | 0.46017295 |
125 | SGK3 | 0.45339913 |
126 | TAOK2 | 0.45111087 |
127 | MAP3K14 | 0.44819195 |
128 | STK4 | 0.43911493 |
129 | PTK2B | 0.43710741 |
130 | EGFR | 0.43096229 |
131 | PIK3CG | 0.42674834 |
132 | TLK1 | 0.41617532 |
133 | NLK | 0.40856259 |
134 | HIPK2 | 0.40260999 |
135 | PRKD1 | 0.38933468 |
136 | * MAPK1 | 0.38406650 |
137 | TAOK3 | 0.35239355 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.07390196 |
2 | Adherens junction_Homo sapiens_hsa04520 | 1.79445374 |
3 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.79081464 |
4 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.77877738 |
5 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.75260273 |
6 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.74986703 |
7 | Allograft rejection_Homo sapiens_hsa05330 | 1.71644971 |
8 | Other glycan degradation_Homo sapiens_hsa00511 | 1.71491089 |
9 | Leishmaniasis_Homo sapiens_hsa05140 | 1.70423523 |
10 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.70278566 |
11 | Viral myocarditis_Homo sapiens_hsa05416 | 1.62805764 |
12 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.59508792 |
13 | Lysine degradation_Homo sapiens_hsa00310 | 1.56846281 |
14 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.50528274 |
15 | * Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.48239458 |
16 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.46408812 |
17 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.45518993 |
18 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.44654706 |
19 | Bladder cancer_Homo sapiens_hsa05219 | 1.43140894 |
20 | Basal cell carcinoma_Homo sapiens_hsa05217 | 1.41648338 |
21 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.40704635 |
22 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.40690287 |
23 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.40364864 |
24 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.39240285 |
25 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.37021190 |
26 | Shigellosis_Homo sapiens_hsa05131 | 1.36443438 |
27 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.35348671 |
28 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.32600340 |
29 | Measles_Homo sapiens_hsa05162 | 1.28999183 |
30 | HTLV-I infection_Homo sapiens_hsa05166 | 1.26941278 |
31 | Focal adhesion_Homo sapiens_hsa04510 | 1.23998169 |
32 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.23172625 |
33 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.22947901 |
34 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.20401544 |
35 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.20151058 |
36 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 1.20075407 |
37 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.18084391 |
38 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.17988158 |
39 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.17888132 |
40 | Base excision repair_Homo sapiens_hsa03410 | 1.17710174 |
41 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.17239560 |
42 | Hepatitis C_Homo sapiens_hsa05160 | 1.16532128 |
43 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.16386570 |
44 | * Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.15535134 |
45 | Hepatitis B_Homo sapiens_hsa05161 | 1.13790506 |
46 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.13390964 |
47 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 1.12817247 |
48 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.10732725 |
49 | Phagosome_Homo sapiens_hsa04145 | 1.10500508 |
50 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.09978659 |
51 | Colorectal cancer_Homo sapiens_hsa05210 | 1.08551979 |
52 | Legionellosis_Homo sapiens_hsa05134 | 1.08499560 |
53 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.07208396 |
54 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.06927465 |
55 | Apoptosis_Homo sapiens_hsa04210 | 1.04137189 |
56 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.03366121 |
57 | Amoebiasis_Homo sapiens_hsa05146 | 1.02805107 |
58 | Malaria_Homo sapiens_hsa05144 | 1.02522433 |
59 | Endocytosis_Homo sapiens_hsa04144 | 0.99696316 |
60 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.99003815 |
61 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.95839244 |
62 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.95261808 |
63 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.94295135 |
64 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.94258962 |
65 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.93989824 |
66 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.92152255 |
67 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.91680354 |
68 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.91338123 |
69 | Mismatch repair_Homo sapiens_hsa03430 | 0.90820671 |
70 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.90486842 |
71 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.89930360 |
72 | Lysosome_Homo sapiens_hsa04142 | 0.88901445 |
73 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.88080206 |
74 | Insulin resistance_Homo sapiens_hsa04931 | 0.88079598 |
75 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.86926029 |
76 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.83755582 |
77 | * Pathways in cancer_Homo sapiens_hsa05200 | 0.83687346 |
78 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.83230338 |
79 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.82646065 |
80 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.82386511 |
81 | Endometrial cancer_Homo sapiens_hsa05213 | 0.80035883 |
82 | Spliceosome_Homo sapiens_hsa03040 | 0.79210642 |
83 | Prostate cancer_Homo sapiens_hsa05215 | 0.79086491 |
84 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.77922976 |
85 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.77922459 |
86 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.77614097 |
87 | Influenza A_Homo sapiens_hsa05164 | 0.76657702 |
88 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.74706534 |
89 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.74479601 |
90 | Thyroid cancer_Homo sapiens_hsa05216 | 0.73889708 |
91 | DNA replication_Homo sapiens_hsa03030 | 0.73499590 |
92 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.73113922 |
93 | RNA transport_Homo sapiens_hsa03013 | 0.72664348 |
94 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.72483381 |
95 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.72459569 |
96 | Tuberculosis_Homo sapiens_hsa05152 | 0.70783220 |
97 | Platelet activation_Homo sapiens_hsa04611 | 0.70533934 |
98 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.70340929 |
99 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.69827205 |
100 | Sulfur relay system_Homo sapiens_hsa04122 | 0.69406157 |
101 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.69298695 |
102 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.69086808 |
103 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.68296512 |
104 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.68255510 |
105 | Cell cycle_Homo sapiens_hsa04110 | 0.67747774 |
106 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.67446811 |
107 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.66781375 |
108 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.66677623 |
109 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.65954964 |
110 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.64968741 |
111 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.64886735 |
112 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.64744195 |
113 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.63880984 |
114 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.63629785 |
115 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.62642768 |
116 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.61268691 |
117 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.61236537 |
118 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.60289900 |
119 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.60277983 |
120 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.59508893 |
121 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.58980528 |
122 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.58826387 |
123 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.58504692 |
124 | Salmonella infection_Homo sapiens_hsa05132 | 0.58366360 |
125 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.57993365 |
126 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.57923969 |
127 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.57448313 |
128 | Glioma_Homo sapiens_hsa05214 | 0.57335707 |
129 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.55823538 |
130 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.55253264 |
131 | Pertussis_Homo sapiens_hsa05133 | 0.54153933 |
132 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.53448962 |
133 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.52067079 |
134 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.51916978 |
135 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.50027837 |